Clinical Trials Directory

Trials / Suspended

SuspendedNCT01268670

The Addition of Oral Analgesics to LET During Laceration Repair

Adjunctive Oral Analgesia for Laceration Repair: Assessing Pain in a Pediatric Emergency Department

Status
Suspended
Phase
N/A
Study type
Interventional
Enrollment
150 (estimated)
Sponsor
Children's Hospitals and Clinics of Minnesota · Academic / Other
Sex
All
Age
4 Years – 10 Years
Healthy volunteers
Not accepted

Summary

Background Approximately 30 million children are treated in emergency departments each year in the United States, of which two to three million are children presenting with lacerations. Topical numbing medication is the standard of care in children with regard to pain control during laceration repair. While topical numbing medications are effective, children often require further pain control during laceration repair in the form of an injected numbing medication, which in itself is painful. No evidence currently exists regarding the concurrent use of oral pain medications to combat laceration procedural pain. Research Question Does the addition of ibuprofen or oxycodone to lidocaine, epinephrine, and tetracaine (LET) topical anesthetic provide more effective pain control than LET alone during laceration repair? Design This is a double-blinded, randomized-controlled study. Methods Subjects in all three groups will receive topical anesthetic. In addition to topical anesthetic, two groups of children will receive either of two oral analgesics, ibuprofen or oxycodone, while the third group will receive a placebo.

Conditions

Interventions

TypeNameDescription
DRUGIbuprofenSubjects will receive topical LET and oral ibuprofen.
DRUGOxycodoneSubjects will receive topical LET and oral oxycodone.
OTHERPlaceboSubjects will receive topical LET and oral placebo.

Timeline

Start date
2012-07-01
Primary completion
2013-07-01
First posted
2010-12-31
Last updated
2013-07-31

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01268670. Inclusion in this directory is not an endorsement.